InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+10.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Girao Tiago, Chief Financial Officer. Director active across 2 companies, notably Immunovant, Inc.. Cumulatively, 7 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €1.3m. History available since 1 May 2025. The latest transaction was filed on 23 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
10,000 sharesCommon StockSEC:0001764013-26-000072:0
10,000 sharesCommon StockSEC:0001764013-26-000072:1
25,760 shares@ US$29.620.012% mcap50.0% of flowCommon StockSEC:0001764013-26-000056
25,760 shares@ US$29.620.012% mcap50.0% of flowCommon StockSEC:0001764013-26-000056:0
208,388 shares0Common StockSEC:0001415889-25-012047:0
35,250 sharesCommon StockSEC:0001140361-16-050458:0
35,250 sharesCommon StockSEC:0001140361-16-049631:0
7 of 7 declarations
About Girao Tiago
Tiago Girao is the Chief Financial Officer of Immunovant, Inc. He is responsible for financial management and strategy, playing a key role in the company's performance.
